Bevacizumab in progressive disseminated atypical choroid plexus papilloma in adults
Neuro Oncol
.
2020 Jul 7;22(7):1046-1047.
doi: 10.1093/neuonc/noaa073.
Authors
Francesca Colò
1
,
Louis Larrouquere
2
,
Romain Rivoirard
3
,
Hugues Loiseau
4
5
,
Augustin Mervoyer
6
,
Alain Lortholary
7
,
Isabelle Catry-Thomas
8
,
Didier Frappaz
1
Affiliations
1
Medical School, University of Trieste, Trieste, Italy.
2
Institute of Pediatric Hematology and Oncology, Leon Bérard Center and Civil Hospices of Lyon, Lyon, France.
3
Medical Oncology Department, Lucien Neuwirth Cancer Institute, Saint-Priest-en-Jarez, France.
4
Department of Neurosurgery, Bordeaux University Hospital, Bordeaux, France.
5
Molecular Imaging and Innovative Therapies in Oncology, University of Bordeaux, Bordeaux, France.
6
Department of Radiation Oncology, Western Cancer Institute, Nantes, France.
7
Confluent Private Hospital, Nantes, France.
8
Saint André Hospital, University Hospital Center, Bordeaux, France.
PMID:
32249894
PMCID:
PMC7339899
DOI:
10.1093/neuonc/noaa073
No abstract available
Publication types
Letter
MeSH terms
Adult
Bevacizumab / therapeutic use
Choroid Plexus Neoplasms*
Glioma
Humans
Papilloma, Choroid Plexus* / drug therapy
Substances
Bevacizumab